Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 283

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model: A Tool to Explore the Pathogenesis of Parkinson's Disease

PRZEDBORSKI, SERGE, VILA, MIQUEL·2003·Annals of the New York Academy of Sciences

Abstract

A bstract:Experimental models of dopaminergic neurodegeneration play a critical role in our quest to elucidate the cause of Parkinson's disease (PD). Despite the recent development of “genetic models” that have followed upon the discovery of mutations causing rare forms of familial PD, toxic models remain at the forefront when it comes to exploring the pathogenesis of sporadic PD. Among these, the model produced by the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) has a competitive advantage over all other toxic models because once this neurotoxin causes intoxication, it induces in humans a syndrome virtually identical to PD. For the past two decades, the complex pharmacology of MPTP and the key steps in the MPTP neurotoxic process have been identified. These molecular events can be classified into three groups: First, those implicated in the initiation of toxicity, which include energy failure due to ATP depletion and oxidative stress mediated by superoxide and nitric oxide; second, those recruited subsequently in response to the initial neuronal perturbations, which include elements of the molecular pathways of apoptosis such as Bax; and, third, those amplifying the neurodegenerative insult, which include various proinflammatory factors such as prostaglandins. Herein, these different contributing factors are reviewed, as is the sequence in which it is believed these factors are acting within the cascade of events responsible for the death of dopaminergic neurons in the MPTP model and in PD. How to target these factors to devise effective neuroprotective therapies for PD is also discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2003.tb07476.x

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Research works printed but not linked: 7

  1. Tetrud J.W., 1986, MPTP‐induced tremor in human and non‐human primates, Neurology, 36, 308
  2. 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F · DOI
  3. Forno L.S., 1993, Similarities and differences between MPTP‐induced parkinsonism and Parkinson's disease: neuropathologic considerations, Adv. Neurol., 60, 600
  4. Przedborski S., 1998, Mechanisms of MPTP toxicity, Mov. Disord., 13, 35
  5. Przedborski S. & T.M. Dawson. 2001. The role of nitric oxide in Parkinson's disease.InParkinson's Disease. Methods and Protocols. M.M. Mouradian Ed.: 113–136. Humana Press. Totowa NJ. · doi:10.1385/1-59259-142-6:113
  6. 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F · DOI
  7. 10.1038/70978 · DOI · Paper page

Cited by

See all 283

Metadata

Authors
PRZEDBORSKI, S., & VILA, M.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2003-06
Volume
991
Issue
1
Pages
189-198
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W4294235631
Cited by
283
References
66
FWCI
9.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model: A Tool to Explore the Pathogenesis of Parkinson's Disease. https://app.cochat.ai/papers/10.1111/j.1749-6632.2003.tb07476.x
The paper
PRZEDBORSKI, S., & VILA, M. (2003). The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model: A Tool to Explore the Pathogenesis of Parkinson's Disease. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2003.tb07476.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.